Gut

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Eherer, A J
Right arrow Articles by Krejs, G J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Eherer, A J
Right arrow Articles by Krejs, G J
Topic Collections
Right arrowRelevant Article
Gut 2002;50:758-764
© 2002 by Gut


OESOPHAGUS

Effect of sildenafil on oesophageal motor function in healthy subjects and patients with oesophageal motor disorders

A J Eherer, I Schwetz, H F Hammer, T Petnehazy, S J Scheidl, K Weber, G J Krejs

Department of Internal Medicine, Karl-Franzens University, Graz, Austria

Correspondence to:
Correspondence to:
A J Eherer, Auenbruggerplatz 15, A-8036 Graz, Austria;
andreas.eherer{at}kfunigraz.ac.at


ABSTRACT
Background and aims: Sildenafil blocks phosphodiesterase type 5 which degrades nitric oxide (NO) stimulated 3`5`-cyclic monophosphate (cGMP), thereby relaxing smooth muscle cells in various organs. We used sildenafil as a tool to investigate the role of the NO-cGMP pathway in the oesophagus of healthy volunteers and patients with hypercontractile oesophageal motility disorders.

Methods: Six healthy male volunteers participated in a randomised double blind study on two separate days before and one hour after oral intake of either sildenafil 50 mg or placebo. Oesophageal manometry was performed to determine vector volume of the lower oesophageal sphincter (LOS) and pressure amplitudes of the oesophageal body. Four of the volunteers underwent 12 hour ambulatory oesophageal manometry on two separate days, once with sildenafil 50 mg and once with placebo. An activity index for spontaneous swallowing was calculated for every hour of the study. Eleven patients with hypercontractile oesophageal motility disorders took part in an open study of the effect of 50 mg sildenafil on manometric features of their disorder and on the clinical response to sildenafil taken as required.

Results: In healthy subjects, sildenafil significantly reduced LOS pressure vector volume and pressure amplitudes in the distal half of the oesophageal body. In three of four subjects the inhibitory effect of sildenafil lasted at least eight hours. In nine of 11 patients, manometric improvement after sildenafil was observed but only four had an improvement in oesophageal symptoms with sildenafil taken as required. Two of these four patients however experienced side effects and did not want to continue treatment.

Conclusions: Sildenafil lowers LOS pressure and propulsive forces in the body of the oesophagus of healthy subjects as well as in patients with nutcracker oesophagus, hypertensive LOS, and achalasia. The effect of sildenafil on the oesophageal body may last for up to eight hours in healthy volunteers. A subset of patients with hypertensive LOS or nutcracker oesophagus may benefit from sildenafil but side effects are a limiting factor.


Keywords: nutcracker oesophagus; lower oesophageal sphincter; achalasia; oesophageal spasm

Abbreviations: cGMP, guanosine 3`5`-cyclic monophosphate; LOS, lower oesophageal sphincter; L-NMMA; N-monomethyl-L-arginine; NO, nitric oxide; PD5, phosphodiesterase type 5; rHb, recombinant haemoglobin; AI, activity index


Relevant Article

Digest
Ian Forgacs
Gut 2002 50: 743. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
S. M. Sims, T. Chrones, and H. G. Preiksaitis
Calcium Sensitization in Human Esophageal Muscle: Role for RhoA Kinase in Maintenance of Lower Esophageal Sphincter Tone
J. Pharmacol. Exp. Ther., October 1, 2008; 327(1): 178 - 186.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. Parker, M. Omine, S. Richards, J.-i. Nishimura, M. Bessler, R. Ware, P. Hillmen, L. Luzzatto, N. Young, T. Kinoshita, et al.
Diagnosis and management of paroxysmal nocturnal hemoglobinuria
Blood, December 1, 2005; 106(12): 3699 - 3709.
[Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
N. Toda and A. G. Herman
Gastrointestinal Function Regulation by Nitrergic Efferent Nerves
Pharmacol. Rev., September 1, 2005; 57(3): 315 - 338.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
R. P. Rother, L. Bell, P. Hillmen, and M. T. Gladwin
The Clinical Sequelae of Intravascular Hemolysis and Extracellular Plasma Hemoglobin: A Novel Mechanism of Human Disease
JAMA, April 6, 2005; 293(13): 1653 - 1662.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
R. Coleski, S. Gonlachanvit, C. Owyang, and W. L. Hasler
Selective Reversal of Hyperglycemia-Evoked Gastric Myoelectric Dysrhythmias by Nitrergic Stimulation in Healthy Humans
J. Pharmacol. Exp. Ther., January 1, 2005; 312(1): 103 - 111.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
R K Mittal and V Bhalla
Oesophageal motor functions and its disorders
Gut, October 1, 2004; 53(10): 1536 - 1542.
[Full Text] [PDF]


Home page
BMJHome page
Minerva
BMJ, June 1, 2002; 324(7349): 1344 - 1344.
[Full Text] [PDF]

eLetters:

Read all eLetters

Sildenafil in gastrointestinal dysmotility disorders
Atul Scahdev, et al.
Gut Online, 7 Nov 2002 [Full text]



HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2002 BMJ Publishing Group Ltd & British Society of Gastroenterology